Do Asian and North American patients with bipolar disorder have similar efficacy, tolerability, and safety profile during clinical trials with atypical antipsychotics?
書誌事項
- 公開日
- 2020-01
- 権利情報
-
- https://www.elsevier.com/tdm/userlicense/1.0/
- https://www.elsevier.com/legal/tdmrep-license
- DOI
-
- 10.1016/j.jad.2019.10.012
- 公開者
- Elsevier BV
この論文をさがす
収録刊行物
-
- Journal of Affective Disorders
-
Journal of Affective Disorders 261 259-270, 2020-01
Elsevier BV
